United Health Products Current Ratio 2015-2024 | UEEC
United Health Products current ratio from 2015 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| United Health Products Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $0.00B | $0.00B | 0.03 |
| 2024-06-30 | $0.00B | $0.00B | 0.01 |
| 2024-03-31 | $0.00B | $0.00B | 0.07 |
| 2023-12-31 | $0.00B | $0.00B | 0.08 |
| 2023-09-30 | $0.00B | $0.00B | 0.07 |
| 2023-06-30 | $0.00B | $0.00B | 0.08 |
| 2023-03-31 | $0.00B | $0.00B | 0.04 |
| 2022-12-31 | $0.00B | $0.00B | 0.03 |
| 2022-09-30 | $0.00B | $0.00B | 0.10 |
| 2022-06-30 | $0.00B | $0.00B | 0.01 |
| 2022-03-31 | $0.00B | $0.00B | 0.02 |
| 2021-12-31 | $0.00B | $0.00B | 0.02 |
| 2021-09-30 | $0.00B | $0.00B | 0.19 |
| 2021-06-30 | $0.00B | $0.00B | 0.08 |
| 2021-03-31 | $0.00B | $0.00B | 0.83 |
| 2020-12-31 | $0.00B | $0.00B | 0.10 |
| 2020-09-30 | $0.00B | $0.00B | 0.07 |
| 2020-06-30 | $0.00B | $0.00B | 0.10 |
| 2020-03-31 | $0.00B | $0.00B | 0.17 |
| 2019-12-31 | $0.00B | $0.00B | 0.09 |
| 2019-09-30 | $0.00B | $0.00B | 0.45 |
| 2019-06-30 | $0.00B | $0.00B | 1.29 |
| 2019-03-31 | $0.00B | $0.00B | 0.16 |
| 2018-12-31 | $0.00B | $0.00B | 0.43 |
| 2018-09-30 | $0.00B | $0.00B | 0.76 |
| 2018-06-30 | $0.00B | $0.00B | 1.24 |
| 2018-03-31 | $0.00B | $0.00B | 0.89 |
| 2017-12-31 | $0.00B | $0.00B | 0.30 |
| 2017-09-30 | $0.00B | $0.00B | 0.29 |
| 2017-06-30 | $0.00B | $0.00B | 0.24 |
| 2017-03-31 | $0.00B | $0.00B | 0.31 |
| 2016-12-31 | $0.00B | $0.00B | 0.21 |
| 2016-09-30 | $0.00B | $0.00B | 0.25 |
| 2016-06-30 | $0.00B | 0.00 | |
| 2016-03-31 | $0.00B | 0.00 | |
| 2015-12-31 | $0.00B | 0.00 | |
| 2015-09-30 | $0.00B | 0.00 | |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
| 2014-12-31 | $0.00B | $0.00B | 0.03 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.020B | $0.000B |
| United Health Products, Inc. develop, manufactures and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds and control bleeding. It serves dental and medical markets. United Health Products, Inc. is based in Henderson, Nevada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $201.700B | 25.73 |
| Stryker (SYK) | United States | $149.044B | 33.59 |
| Boston Scientific (BSX) | United States | $133.337B | 38.33 |
| Medtronic (MDT) | Ireland | $109.905B | 16.33 |
| EssilorLuxottica (ESLOY) | France | $109.555B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.954B | 28.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.657B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.724B | 19.57 |
| ResMed (RMD) | United States | $36.245B | 29.78 |
| Terumo (TRUMY) | Japan | $30.887B | 43.62 |
| Koninklijke Philips (PHG) | Netherlands | $24.833B | 19.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.045B | 14.03 |
| Insulet (PODD) | United States | $18.915B | 75.32 |
| Baxter (BAX) | United States | $16.916B | 11.01 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.223B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.898B | 39.82 |
| Bio-Rad Laboratories (BIO) | United States | $9.303B | 31.62 |
| Demant (WILYY) | Denmark | $8.565B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.154B | 14.30 |
| Haemonetics (HAE) | United States | $4.282B | 20.90 |
| Prestige Consumer Healthcare (PBH) | United States | $4.186B | 20.82 |
| Perrigo (PRGO) | Ireland | $3.877B | 11.41 |
| ICU Medical (ICUI) | United States | $3.835B | 36.51 |
| Envista Holdings (NVST) | United States | $3.786B | 28.20 |
| Agios Pharmaceuticals (AGIO) | United States | $3.358B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.914B | 18.68 |
| Neogen (NEOG) | United States | $2.871B | 33.12 |
| QuidelOrtho (QDEL) | United States | $2.694B | 17.34 |
| LeMaitre Vascular (LMAT) | United States | $2.361B | 57.39 |
| Green Thumb Industries (GTBIF) | United States | $1.940B | 33.95 |
| AtriCure (ATRC) | United States | $1.761B | 0.00 |
| InMode (INMD) | Israel | $1.606B | 9.66 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.364B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.289B | 9.21 |
| BioLife Solutions (BLFS) | United States | $1.244B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.183B | 0.00 |
| Owens & Minor (OMI) | United States | $1.106B | 8.64 |
| CeriBell (CBLL) | United States | $1.056B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 16.61 |
| National Vision Holdings (EYE) | United States | $0.893B | 29.84 |
| Evolus (EOLS) | United States | $0.830B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.751B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.673B | 29.76 |
| Omeros (OMER) | United States | $0.641B | 0.00 |
| Surmodics (SRDX) | United States | $0.566B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.537B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.495B | 0.00 |
| Quanterix (QTRX) | United States | $0.452B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| ZimVie (ZIMV) | United States | $0.407B | 34.30 |
| Biote (BTMD) | United States | $0.360B | 7.89 |
| Viemed Healthcare (VMD) | United States | $0.339B | 32.22 |
| Cerus (CERS) | United States | $0.329B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.318B | 0.00 |
| Valneva SE (VALN) | France | $0.316B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.286B | 19.15 |
| High Tide (HITI) | Canada | $0.284B | 117.67 |
| Zynex (ZYXI) | United States | $0.259B | 54.20 |
| Aurora Cannabis (ACB) | Canada | $0.242B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.226B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.218B | 15.08 |
| MacroGenics (MGNX) | United States | $0.216B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.183B | 2.58 |
| Brainsway (BWAY) | Israel | $0.170B | 102.10 |
| Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.152B | 19.06 |
| Jin Medical (ZJYL) | China | $0.135B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.128B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.116B | 0.00 |
| Veru (VERU) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.102B | 11.49 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.099B | 0.00 |
| Exagen (XGN) | United States | $0.083B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.071B | 36.67 |
| Jushi Holdings (JUSHF) | United States | $0.065B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.062B | 0.00 |
| Apyx Medical (APYX) | United States | $0.062B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.060B | 0.00 |
| Modular Medical (MODD) | United States | $0.058B | 0.00 |
| Safety Shot (SHOT) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| MariMed (MRMD) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.023B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.88 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |